Details of the Drug Formulations

General Information of Drug (ID: DMSZQAK)

Drug Name
Amphetamine Drug Info
Synonyms Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD); Amphetamine (tamper and abuse-resistant, Bio-MD/MPAR, ADHD), PharmacoFore; PF-08 (Bio-MD/MPAR/prodrug/oral, ADHD), PharmacoFore
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Approved [1]
Cross-matching ID
PubChem CID
3007
ChEBI ID
CHEBI:2679
CAS Number
300-62-9
TTD ID
D05BMG
VARIDT ID
DR00084
INTEDE ID
DR0106
ACDINA ID
D00036

Full List of Drug Formulations Containing This Drug

Amphetamine 12.5 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01310 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 15.7 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01311 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 18.8 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01312 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 3.1 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01313 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 6.3 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01314 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 9.4 mg tablet
Company Formulation ID FDA Description
Neos Therapeutics F01315 Sucralose; Fructose; Magnesium stearate; Mannitol; Citric acid monohydrate; Triethyl citrate; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Methacrylic acid; Microcrystalline cellulose; Polyethylene glycol, unspecified; Sodium polystyrene sulfonate
------------------------------------------------------------------------------------
Amphetamine 10 mg tablet
Company Formulation ID FDA Description
Arbor Pharmaceuticals F01317 Stearic acid; Fd&c blue no. 1; Crospovidone; Cellulose, microcrystalline
Arbor Pharmaceuticals F01316 Stearic acid; Fd&c blue no. 1; Crospovidone (15 mpa.s at 5%); Microcrystalline cellulose
------------------------------------------------------------------------------------
Amphetamine 5 mg tablet
Company Formulation ID FDA Description
Arbor Pharmaceuticals F01319 Stearic acid; Crospovidone; Cellulose, microcrystalline
Arbor Pharmaceuticals F01318 Stearic acid; Crospovidone (15 mpa.s at 5%); Microcrystalline cellulose
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015